Evidence map›Paper›PMID 27532494›Full record

ArticleJournal of breath research2016

Stool microbiome reveals diverse bacterial ureases as confounders of oral urea breath testing for Helicobacter pylori and Mycobacterium tuberculosis in Bamako, Mali.

Mamoudou Maiga, Keira Cohen, Bocar Baya, Geetha Srikrishna, Sophia Siddiqui, Moumine Sanogo, Anou M Somboro, Bassirou Diarra, Mariam H Diallo, Varun Mazumdar and 13 more

Open access · greenAbstract read
In one paragraph

Article in Journal of breath research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 2 countries.

Mamoudou MaigaSEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Keira CohenDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115, USA.
Bocar BayaSEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Geetha SrikrishnaCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Sophia SiddiquiDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Moumine SanogoSEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Anou M SomboroSEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Bassirou DiarraSEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Mariam H DialloSEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Varun MazumdarThe Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Christian YoderDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Susan OrsegaDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Michael BelsonDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Hamadoun KassambaraSEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Drissa GoitaSEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Robert L MurphyDivision of Infectious Diseases, Northwestern University, Chicago, IL, USA.
Sounkalo DaoSEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Michael PolisDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Souleymane DialloSEREFO HIV/TB, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Graham S TimminsDivision of Pharmaceutical Sciences, University of New Mexico, Albuquerque, NM, USA.
Lori DoddDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Ashlee M EarlThe Broad Institute of MIT and Harvard, Cambridge, MA, USA.
William R BishaiCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Université des Sciences, des Techniques et des Technologies de Bamako · MLNational Institute of Allergy and Infectious Diseases · USBroad Institute · USJohns Hopkins University · USBrigham and Women's Hospital · USJohns Hopkins Medicine · USNorthwestern University · USUniversity of New Mexico · US

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI NEAFSEY, DANIEL E · 2014 to 2024
$66.5M
Northwestern University Clinical Trial UnitUM1AI069471 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Chad J Achenbach · 2012 to 2026
$24.6M
Northwestern University Clinical Trial UnitU01AI069471 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MURPHY, ROBERT LEO · 2007 to 2011
$12.0M
Mycobacterium tuberculosis Survival Regulatory GenesR01AI037856 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 1997 to 2020
$7.2M
GENE REGULATION AND VIRULENCE IN TB AND MACR01AI036973 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 1999 to 2014
$5.7M
Biomarkers and Signaling in TuberculosisR01AI097138 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 2011 to 2014
$2.4M
Host-Pathogen Interactions in a Failing Global lineage of MTBC:M.africanumR01AI110386 · NIAID · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI DIALLO, SOULEYMANE · 2014 to 2018
$1.2M
NIAID NIH HHS HHSN272200900018CNIAID NIH HHS R01 AI036973NIAID NIH HHS R01 AI037856NIAID NIH HHS R01 AI097138NIAID NIH HHS R01 AI110386NIAID NIH HHS U01 AI069471NIAID NIH HHS U19 AI110818NIAID NIH HHS UM1 AI069471
6 · The paper itself

Abstract

Detection of bacterial urease activity has been utilized successfully to diagnose Helicobacter pylori (H. pylori). While Mycobacterium tuberculosis (M. tuberculosis) also possesses an active urease, it is unknown whether detection of mycobacterial urease activity by oral urease breath test (UBT) can be exploited as a rapid point of care biomarker for tuberculosis (TB) in humans. We enrolled 34 individuals newly diagnosed with pulmonary TB and 46 healthy subjects in Bamako, Mali and performed oral UBT, mycobacterial sputum culture and H. pylori testing. Oral UBT had a sensitivity and specificity (95% CI) of 70% (46-88%) and 11% (3-26%), respectively, to diagnose culture-confirmed M. tuberculosis disease among patients without H. pylori, and 100% sensitivity (69-100%) and 11% specificity (3-26%) to diagnose H. pylori among patients without pulmonary TB. Stool microbiome analysis of controls without TB or H. pylori but with positive oral UBT detected high levels of non-H. pylori urease producing organisms, which likely explains the low specificity of oral UBT in this setting and in other reports of oral UBT studies in Africa.

Indexed as

MicrobiotaAdultBreath TestsDemographyFecesFemaleHelicobacter InfectionsHelicobacter pyloriHumansMaleMaliMiddle AgedMycobacterium tuberculosisSensitivity and SpecificityTuberculosisUreaUreaUrease

Identifiers

PMID27532494
PMCPMC5046223
OpenAlexW2510689957

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.